You are not seeing that right.
The FDA isn't involved in any kind of "Fraud" what-so-ever.
The FDA is doing what they are responsible to do - report a violation when they see it (albeit, it took them over 4 weeks to do so, which in my opinion has some questionable aspects to it!).
The FDA didn't make any instructions to investors in their statement. It is up to YOU (as it always is) to analyze the information and come to your own conclusions.
Bottom line here is that the FDA had to report this, in as dry terms as possible, and in alignment with their protocols.
BUT, anyone truly looking into this can see that it is all BS.
ABSOLUTELY NOTHING has changed in regards to the merits of Immunopass, or even the test results for that matter.
Whether you sell on this news, or buy on this news (or hold on this news) is entirely your choice.
The FDA merely has a social obligation, based upon its founding principles, to put this information out there, regardless of how truly meaningless and trivial that information might be.
IF the FDA "covered this up" and didn't make a statement, perhaps then there would have been "Fraud" on their behalf.
.....but the FDA did its job! It is up to YOU the investor as to how you feel comfortable interpreting that information.
....and I, personally, believe it is a bunch of BS and a sign that the FDA is in its final stages before issuing its EUA.
You see, the FDA has to dot its "i"s and cross its "t"s just like anyone else, before it publicizes its final decision.
IMHO, this announcement was exactly that - merely a CYA and making sure to cover all bases, before the FDA wraps this one up and gives it its final stamp of approval.
......and based on my beliefs, I intend to buy some cheapies next week if the opportunity (ie: spare funds) affords it.......
News 
Market Data 
Discover 
AI
